Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $22.3 million.

  • Acadia Healthcare Company's Change in Receivables rose 53062.96% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.4 million, marking a year-over-year increase of 13503.37%. This contributed to the annual value of $2.3 million for FY2024, which is 9403.0% down from last year.
  • According to the latest figures from Q3 2025, Acadia Healthcare Company's Change in Receivables is $22.3 million, which was up 53062.96% from $11.7 million recorded in Q2 2025.
  • In the past 5 years, Acadia Healthcare Company's Change in Receivables registered a high of $31.0 million during Q1 2025, and its lowest value of -$18.6 million during Q4 2024.
  • For the 5-year period, Acadia Healthcare Company's Change in Receivables averaged around $7.7 million, with its median value being $6.4 million (2022).
  • Data for Acadia Healthcare Company's Change in Receivables shows a peak YoY increase of 65761.82% (in 2024) and a maximum YoY decrease of 143144.03% (in 2024) over the last 5 years.
  • Acadia Healthcare Company's Change in Receivables (Quarter) stood at -$11.1 million in 2021, then soared by 158.24% to $6.4 million in 2022, then plummeted by 118.87% to -$1.2 million in 2023, then plummeted by 1431.44% to -$18.6 million in 2024, then surged by 219.84% to $22.3 million in 2025.
  • Its last three reported values are $22.3 million in Q3 2025, $11.7 million for Q2 2025, and $31.0 million during Q1 2025.